Yield10 Bioscience, Inc. (YTEN)

USD 0.34

(-51.78%)

Market Cap (In USD)

345.46 Thousand

Revenue (In USD)

60 Thousand

Net Income (In USD)

-14.45 Million

Avg. Volume

5094.00

Currency
USD
Country
Basic Materials
Open
-
Prev. Close
-
Day Range
-
Year Range
0.2352-17.255999
PE
-0.0166
EPS
-20.14
Beta Value
1.433
ISIN
US98585K8624
CUSIP
98585K862
CIK
1121702
Shares
1031069.0
Earnings Annoncement
-

Company Profile

Sector
Basic Materials
Industry
Agricultural Inputs
CEO
Dr. Oliver P. Peoples Ph.D.
Employee Count
-
Website
https://www.yield10bio.com
Ipo Date
2006-11-10
Details
Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. The company, through its Trait Factory, a trait gene discovery platform develops enhanced oilseed Camelina sativa for the production of proprietary seed products; and discovers high value genetic traits for the agriculture and food industries. Yield10 Bioscience, Inc. has license agreements with GDM Seeds; J. R. Simplot; Forage Genetics International, LLC; and Bayer AG. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporate in 1992 and is headquartered in Woburn, Massachusetts.